CGON CG Oncology Inc.
Stable Earnings Power
F 28.2 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 28.2 pillar composite — hard gates always win.

Profitability

Weight: 20%
F 0
  • 5yr Avg ROIC -16.9%
  • Operating Margin Trend -81.47 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -24.0%

Growth Quality

Weight: 15%
C+ 60
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 15%
F 0
  • 5yr FCF Margin -9669.3%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 20%
C 55
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 97.97

Stability

Weight: 15%
C 54
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 3

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed; 1 full exit.

Holders
2
Avg Δ position
+13.7%
New buys
0
Full exits
1
As of Q2 2026